A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of

A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM)

Abierta

Código protocolo: ITL-2001-CL-301
Código EudraCT: No aplica
Grupo de investigación: Enfermedades Sistémicas
Servicio: Medicina Interna
Investigador/a principal: Martínez Valle, Fernando
Patología: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
Fase: Fase III